Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06817096 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
2\. Participants will: * Take nitazoxanide 600mg (or placebo) orally twice daily for 7 days, for a total of 14 doses. * Visit the clinic on the 7th day of treatment for a check-up and safety tests. * Keep a diary of their symptoms and other medications used
Trial Details
NCT Number NCT06817096
Lead Sponsor Azidus Brasil
Collaborators: Farmoquimica S.A.
Conditions
(from sponsor)		 Covid 19, Influenza
Related terms COVID-19, Influenza, Human
Enrollment 340 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov